Investor Information

News

Summit Therapeutics Reports Financial Results and Operational Progress for the Fourth Quarter and Year Ended December 31, 2023

View News

Summit Therapeutics to Host Fourth Quarter & Full Year 2023

View News

More Information

Share Price

NASDAQ: SMMT

4.11 USD

21-Feb-2024 16:00 UTC-5

More Information

SEC Filings

Annual report pursuant to section 13 and 15(d)

View News

Registration statement for specified transactions by certain issuers

View News

More Information

Email Alerts